Literature DB >> 2468624

Thymosin, interleukins, isoprinosine and imuthiol do not reconstitute T-cells in athymic nude mice.

J W Hadden1, G Caspritz, Q Y Zheng, H Chen, R Wolstencroft, E M Hadden.   

Abstract

Previous reports suggest that immunotherapy can induce T-cell development in athymic nude mice. Eight-week-old BALB/c nu/nu (athymic nude) mice were treated for 3, 6 and 12 weeks with thymosin fraction 5 (TF-5), buffy coat interleukins (BC-IL), recombinant IL-2 (rIL-2), a combination of TF-5 and BC-IL, isoprinosine or imuthiol. Control animals were treated with sterile saline or were given a syngeneic thymus graft. Spleen weight, cell yields and Thy 1.2+ T-cell markers were monitored and spleen cell proliferative responses to rIL-2, concanavalin A (Con A), Con A + rIL-2, phytohemagglutinin (PHA) and endotoxin (LPS) were assessed. Only mice transplanted with a syngeneic thymus showed progressive increases in both T-cell number and function. Minor changes in proliferative responses were noted at 3 weeks with all treatments; however, no biologically significant reconstitution of T-cell number or function was observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468624     DOI: 10.1016/0192-0561(89)90094-5

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  1 in total

Review 1.  Therapy of secondary T-cell immunodeficiencies with biological substances and drugs.

Authors:  J W Hadden; E M Hadden
Journal:  Med Oncol Tumor Pharmacother       Date:  1989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.